Skip to main content
Article thumbnail
Location of Repository

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

By Yan Feng, Bruce G Pollock, Kim Coley, Stephen Marder, Del Miller, Margaret Kirshner, Manickam Aravagiri, Lon Schneider and Robert R Bies

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECTRisperidone metabolism is affected by blocking CYP2D6 and CYP3A4 (in CYP2D6 poor metabolizers) metabolizing enzymes.Age affects risperidone disposition and renal function affects elimination of 9-hydroxy-risperidone (primary active metabolite)

Topics: Pharmacokinetics
Publisher: Blackwell Science Inc
OAI identifier: oai:pubmedcentral.nih.gov:2661978
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.